(photo: )

US nod for first immunotherapy approved for rare skin cancer

The US Food & Drug administration has approved its first treatment for mestastic Merkel cell carcinoma, a rare and aggressive type of skin cancer.

R&D

Manufacturing

Packaging

Finance

Highlights

Legislation

 (photo: )

NICE to fast-track more drug approvals

UK patients will benefit from access to the most cost-effective treatments nearly 5 months faster after changes to the NICE drug evaluation process were approved.

 (photo: )

ABPI welcomes Prime Minister’s speech negotiating Brexit

The UK pharmaceutical industry trade body, the Association of the British Pharmaceutical Industry (ABPI), has welcomed the Prime Minister’s speech on the Government’s negotiating objectives for exiting the EU.

Logistics

 (photo: )

Sobi enters new distribution agreement with Valeant for Ammonul

Swedish Orphan Biovitrum (Sobi) has entered into a 3-year agreement with Valeant Pharmaceuticals Ireland for the distribution of Ammonul injection in Europe, the Middle East and North Africa.

 (photo: )

Yorkshire pharma startup ships first medicines to Iraq

The first consignment of British manufactured medicines has been exported to Iraq by a new Yorkshire pharmaceuticals wholesaler and distributor set up to give Iraqi people access to high-quality treatments.

Marketing

 (photo: )

US nod for first immunotherapy approved for rare skin cancer

The US Food & Drug administration has approved its first treatment for mestastic Merkel cell carcinoma, a rare and aggressive type of skin cancer.

 (photo: )

FDA approve add-on for Parkinson’s disease treatment

Newron Pharmaceuticals has gained approval from the US Food and Drug Administration for Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes.